Will advance the biotech company's lead antibody-drug conjugate (ADC) program.

Halozyme Therapeutics is appointing David Ramsay Interim Chief Financial Officer (CFO), effective March 23, 2026.

Fujifilm Biotechnologies has appointed Christiane Bardroff as Chief Business Officer (CBO), effective June 1, 2026.

BioDuro, a global CRDMO, has appointed Andrew Thomas, Ph.D., and Stevan Djuric, Ph.D., as scientific advisors.

SK pharmteco has announced the successful CGMP qualification of its manufacturing facility in Corbeil-Essonnes, France.

Trenchant BioSystems Inc. and Invetech have entered into a strategic alliance focused on the continued development of Trenchant’s fully automated AutoCell Platform.

Coriolis Pharma has opened a new U.S. headquarters and laboratory at the Alexandria Center for Advanced Technologies in North Carolina’s Research Triangle Park.

Agilent Technologies is launching Agilent Advanced Therapeutics, a unified CDMO solution integrating capabilities in Canada and the U.S.

Bespak is increasing pressurized metered dose inhaler manufacturing capacity to support Chiesi Group’s Carbon Minimal Inhaler (CMI) program.

Lilly plans to invest $3 billion over the next 10 years to boost its manufacturing operations in China, according to a March 11 press release from Lilly’s Chinese operations. Lilly plans to set up ...

Almirall has inaugurated new offices in the Jing’an district in Shanghai, China, to further opportunities for innovation in medical dermatology. To be known as Almirall Shanghai Pharmaceutical ...

Lyocontract and its partner Syntegon recently held a groundbreaking ceremony for a 50-million-euro ($57.6 million) production expansion in Germany. “With the groundbreaking ceremony, we are paving the ...